Vibratome to generate organotypic tumor slices from patients' specimen
The National Institutes of Health (NIH) intends to award a non-competitive contract to Government Scientific Source, Inc. for a Leica Vibratome, a precision instrument used to cut living tissue slices from patient tumor samples for personalized cancer treatment research. The instrument supports clinical trials, particularly for glioma, by enabling drug testing on living tumor slices to design individualized treatment plans. The contract will be awarded under simplified acquisition procedures, with an amount not exceeding the simplified acquisition threshold of $350,000. Performance will be at the NIH location in Bethesda, Maryland. Interested parties must submit responses by the specified deadline to be considered.